Not a bad follow up article as GSK also made a $2b deal for Bellus Health.
https://www.fiercepharma.com/pharma/big-pharmas-finally-strike-gsk-merck-acquisitions-signaling-accelerating-pace-ma
From the article:
Moody’s Investor Services thinks these are just the start, with M&A activity expected to remain high over the next year to 18 months. Pharmas are trying to restock their pipelines due to approaching patent cliffs and long-term pricing pressure, Moody’s wrote in a Monday sector commentary note.
Other Big Pharmas that are likely to strike include Bristol Myers Squibb, Royalty Pharma and Merck again, according to Moody's. AbbVie, Biogen, Gilead, Pfizer and Viatris also have moderate potential for deals, the firm says, while Amgen, Eli Lilly, Johnson & Johnson and Regeneron are less likely.
Merck to acquire Prometheus in a US$ 10.8 b deal, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$14.37 |
Change
0.170(1.20%) |
Mkt cap ! $1.797B | |||
| Open | High | Low | Value | Volume |
| $14.22 | $14.55 | $14.10 | $3.754M | 260.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1 | $14.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.38 | 477 | 9 |
View Market Depth
| Last trade - 15.19pm 04/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |